Art

J-GLOBAL ID：201802266696715171   Reference number：18A0527271

Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma

ホスホイノシチド依存性蛋白質キナーゼ1は,マントル細胞リンパ腫における有望な新規治療標的である【Powered by NICT】

Author (15)： Maegawa Saori (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Chinen Yoshiaki (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Shimura Yuji (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Tanba Kazuna (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Takimoto Tomoko (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Mizuno Yoshimi (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Matsumura-Kimoto Yayoi (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Kuwahara-Ota Saeko (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Tsukamoto Taku (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Kobayashi Tsutomu (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Horiike Shigeo (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Taniwaki Masafumi (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Taniwaki Masafumi (Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan) ,  Kuroda Junya (Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Kuroda Junya (Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan)
Material： Experimental Hematology  (Exp Hematol)
Volume： 59  Page： 72-81.e2  Publication year： 2018 
JST Material Number： T0591A  ISSN： 0301-472X  CODEN： EXHMA  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Mantle cell lymphoma (MCL) is ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0527271&from=J-GLOBAL&jstjournalNo=T0591A") }}

Thesaurus term： phosphorylation ,  B cell lymphoma ,  tumor cell ,  apoptosis ,  molecular targeting drug ,  inhibition of multiplication ,  *protein kinase ,  therapeutic planning ,  antitumor drug ,  RNA interference ,  molecular target therapy
Semi thesaurus term： 細胞株 ,  阻害剤 ,  *治療標的 ,  *マントル細胞リンパ腫 , 【Automatic Indexing@JST】

JST classification (1)： Blood cell tumors(=neoplasms)  (GK04000M)

Terms in the title (5)： ホスホイノシチド ,  依存性 ,  蛋白質キナーゼ ,  マントル細胞リンパ腫 ,  治療標的